中證網訊 三諾(nuo)生物(300298)7月11日晚間發布2018 年半年度業績預告。根據公告,報告期內公歸屬(shu)于上市公司(si)股東的凈利潤(run)盈利 14,971.54萬(wan)元—17,778.70萬(wan)元,比上年同期增長(chang)60%—90%。
公(gong)(gong)(gong)(gong)司(si)(si)表示,期(qi)內(nei)業績變動主(zhu)要(yao)原(yuan)因是公(gong)(gong)(gong)(gong)司(si)(si)銷(xiao)售(shou)(shou)收(shou)入(ru)較去(qu)年(nian)同期(qi)相比繼(ji)續(xu)保(bao)持(chi)穩健(jian)增(zeng)長(chang),加之產品(pin)銷(xiao)售(shou)(shou)結構也有(you)(you)所改善,使得產品(pin)銷(xiao)售(shou)(shou)毛利率繼(ji)續(xu)保(bao)持(chi)增(zeng)長(chang);2018年(nian)1月,公(gong)(gong)(gong)(gong)司(si)(si)完成了對長(chang)沙三(san)諾(nuo)健(jian)康(kang)管(guan)理有(you)(you)限公(gong)(gong)(gong)(gong)司(si)(si)的重(zhong)大資產重(zhong)組(zu),并將其(qi)納入(ru)公(gong)(gong)(gong)(gong)司(si)(si)合并報表范圍,使得公(gong)(gong)(gong)(gong)司(si)(si)合并凈利潤有(you)(you)所增(zeng)加;報告(gao)期(qi)內(nei)公(gong)(gong)(gong)(gong)司(si)(si)非經常性(xing)損益預計為(wei)3,000萬元—3,500萬元。主(zhu)要(yao)為(wei)公(gong)(gong)(gong)(gong)司(si)(si)對長(chang)沙三(san)諾(nuo)健(jian)康(kang)管(guan)理有(you)(you)限公(gong)(gong)(gong)(gong)司(si)(si)進行重(zhong)大資產重(zhong)組(zu)前持(chi)有(you)(you)的股權(quan)按公(gong)(gong)(gong)(gong)允價(jia)值重(zhong)新計量(liang)而確認的股權(quan)增(zeng)值投資收(shou)益。(楊寧)